TC-6987

DRUG2 trials

Sponsors

Targacept Inc.

Conditions

AsthmaType 2 Diabetes Mellitus

Phase 2

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

CompletedNCT01293669

Targacept Inc.Type 2 Diabetes Mellitus

Start: 2011-01-31End: 2012-01-31Updated: 2013-09-13

TC-6987 for the Treatment of Mild to Moderate Asthma

CompletedNCT01296087

Targacept Inc.Asthma

Start: 2011-02-28End: 2012-01-31Updated: 2013-09-13